METHOD OF MODELLING OF PULMONARY EDEMA

FIELD: experimental medicine; applicable in modelling of pulmonary edema in experiment. SUBSTANCE: method includes introduction to animals of paraopiodic dipeptide arginylphenylalanine in form of dihydrochloride (RFx2HCl) in doses from 0.1 to 0.5 mg/g. Method allows exclusion of use of catechol amin...

Full description

Saved in:
Bibliographic Details
Main Authors MALINOVSKAJA I.V, BESPALOVA ZH.D, TINJAKOV R.L, PARIN S.B, PONOMARENKO A.A
Format Patent
LanguageEnglish
Published 27.12.1999
Edition6
Subjects
ADVERTISING
APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND,DEAF OR MUTE
CRYPTOGRAPHY
DIAGRAMS
DISPLAY
EDUCATION
EDUCATIONAL OR DEMONSTRATION APPLIANCES
GLOBES
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PHYSICS
PLANETARIA
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SEALS
Online AccessGet full text

Cover

More Information
Summary:FIELD: experimental medicine; applicable in modelling of pulmonary edema in experiment. SUBSTANCE: method includes introduction to animals of paraopiodic dipeptide arginylphenylalanine in form of dihydrochloride (RFx2HCl) in doses from 0.1 to 0.5 mg/g. Method allows exclusion of use of catechol amines, and adequate assessment of sympathoadrenal system and investigation of dynamic of its functions in formation of pulmonary edema. EFFECT: higher efficiency. 2 tbl, 1 ex
Bibliography:Application Number: RU19970117810